Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Shenoy, Niraj
Associate Professor
Bio
The Shenoy Lab is interested in understanding and targeting the interactions between aberrant metabolism, epigenetic dysregulation, and immune evasion in cancer. While kidney cancer (clear cell r... [more]
Shilatifard, Ali
Professor
Bio
I hold the Robert Francis Furchgott Professorship and am the Chairman of the Department of Biochemistry and Molecular Genetics at Northwestern University Feinberg School of Medicine. I continue to run... [more]
Shukla, Vipul
Assistant Professor
Bio
My research broadly focuses on understanding the roles of cytosine modifications and alternative DNA structures in normal and cancer genomes. I am currently investigating the functions of G-quadruplex... [more]
Singhal, Seema
Professor
Bio
Myeloma, Transplantation
Siziopikou, Kalliopi P.
Professor
Bio
Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive sign... [more]
Sokol, Elizabeth
Assistant Professor
Bio
My contributions to medicine at this time have involved optimization of risk classification in patients with neuroblastoma. I was involved in a study looking at the methods of scoring MIBG scans and q... [more]
Sonabend, Adam
Associate Professor
Bio
Dr Sonabend's research focuses on Topoisomerase II-mediated transcriptional regulation in gliomas, and personalized use of TOP2- targeting chemotherapy to treat malignant brain cancer. He is also... [more]
Sosman, Jeffrey
Professor
Bio
I am a clinical investigator vested in the immune-based and targeted therapy of melanoma. I have played a role in the clinical development of the immune checkpoint inhibitors. I am involved in effort... [more]
Stein, Brady
Professor
Bio
Dr. Stein is interested in the clinical investigation and clinical epidemiology of the classical Myeloproliferative Neoplasms. He has focused on the correlation between molecular and genetic abnormal... [more]
Strauss, Jonathan B.
Associate Professor
Bio
Dr. Strauss focuses his clinical practice in radiation oncology for breast and gynecological malignancies. He is an active and prolific clinical researcher. Dr. Strauss has focused more recently on ad... [more]